GLRA
PETX

Gerald L. Ray & Associates’s Aratana Therapeutics, Inc. PETX Stock Holding History

Gerald L. Ray & Associates’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-24,100
Closed -$174K – 336
2017
Q2 		$174K Buy
24,100
+200
+0.8% +$1.44K 0.02% 313
2017
Q1 		$127K Buy
23,900
+6,600
+38% +$35.1K 0.02% 312
2016
Q4 		$124K Buy
17,300
+1,000
+6% +$7.17K 0.02% 308
2016
Q3 		$153K Buy
+16,300
New +$153K 0.02% 313